CRIDLAND; Andrew Peter
Patent Applications and Registrations
Patent applications and USPTO patent grants for CRIDLAND; Andrew Peter.The latest application filed is for "enzyme inhibitors".
- CRIDLAND; Andrew Peter - Harlow Essex GB
- Cridland; Andrew Peter - Margate GB
- Cridland; Andrew Peter - Margate Kent GB
- Cridland; Andrew Peter - Harlow GB
- Cridland; Andrew Peter - Cambridge GB
- Cridland; Andrew Peter - Essex GB
| Patent | Date |
|---|---|
| Enzyme Inhibitors App 20220298138 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
| Enzyme Inhibitors App 20220298141 - DAVIE; Rebecca Louise ; et al. | 2022-09-22 |
| Indane Derivatives For Use In The Treatment Of Bacterial Infection App 20220112169 - Leiris; Simon ; et al. | 2022-04-14 |
| Indane Derivatives For Use In The Treatment Of Bacterial Infection App 20210347748 - Leiris; Simon ; et al. | 2021-11-11 |
| Chemical compounds as antibiotics Grant 11,000,511 - Leiris , et al. May 11, 2 | 2021-05-11 |
| Chemical Compounds As Antibiotics App 20200155509 - LEIRIS; Simon ; et al. | 2020-05-21 |
| Derivatives of [1, 2, 4] triazolo [4, 3-a] pyridine as P38--MAP kinase inhibitors Grant 9,573,949 - Alcaraz , et al. February 21, 2 | 2017-02-21 |
| Kinase inhibitors Grant 9,527,846 - Van Niel , et al. December 27, 2 | 2016-12-27 |
| Kinase inhibitors Grant 9,440,974 - Alcaraz , et al. September 13, 2 | 2016-09-13 |
| Kinase Inhibitors App 20160229852 - VAN NIEL; Monique Bodil ; et al. | 2016-08-11 |
| Derivatives Of [1, 2, 4] Triazolo [4, 3 - A] Pyridine As P38 - Map Kinase Inhibitors App 20160108040 - ALCARAZ; Lilian ; et al. | 2016-04-21 |
| Kinase inhibitors Grant 9,315,503 - Van Niel , et al. April 19, 2 | 2016-04-19 |
| Kinase Inhibitors App 20160016953 - ALCARAZ; Lilian ; et al. | 2016-01-21 |
| Kinase Inhibitors App 20150344475 - VAN NIEL; Monique Bodil ; et al. | 2015-12-03 |
| Kinase inhibitors Grant 9,181,242 - Alcaraz , et al. November 10, 2 | 2015-11-10 |
| Kinase inhibitors Grant 9,145,413 - Van Niel , et al. September 29, 2 | 2015-09-29 |
| Kinase inhibitors Grant 9,139,584 - Van Niel , et al. September 22, 2 | 2015-09-22 |
| Kinase inhibitors Grant 9,029,373 - Van Niel , et al. May 12, 2 | 2015-05-12 |
| Kinase Inhibitors App 20150080375 - Van Niel; Monique Bodil ; et al. | 2015-03-19 |
| Kinase Inhibitors App 20140364412 - Alcaraz; Lilian ; et al. | 2014-12-11 |
| Kinase inhibitors Grant 8,907,094 - Van Niel , et al. December 9, 2 | 2014-12-09 |
| Kinase Inhibitors App 20140343055 - Van Niel; Monique Bodil ; et al. | 2014-11-20 |
| Kinase Inhibitors App 20140323470 - VAN NIEL; Monique Bodil ; et al. | 2014-10-30 |
| Kinase inhibitors Grant 8,835,431 - Van Niel , et al. September 16, 2 | 2014-09-16 |
| Piperazine derivatives for blocking Ca.sub.v2.2 calcium channels Grant 8,697,703 - Heer , et al. April 15, 2 | 2014-04-15 |
| Piperazine derivatives used as CAV2.2 calcium channel modulators Grant 8,530,478 - Beswick , et al. September 10, 2 | 2013-09-10 |
| Kinase Inhibitors App 20130150343 - VAN NIEL; Monique Bodil ; et al. | 2013-06-13 |
| Kinase Inhibitors App 20130150361 - Van Niel; Monique Bodil ; et al. | 2013-06-13 |
| PIPERAZINE DERIVATIVES FOR BLOCKING Cav2.2 CALCIUM CHANNELS App 20130072499 - Heer; Jag Paul ; et al. | 2013-03-21 |
| Piperazine Derivatives Used As Cav2.2 Calcium Channel Modulators App 20110130379 - Beswick; Paul John ; et al. | 2011-06-02 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 